Robert Silverman - Net Worth and Insider Trading
Robert Silverman Net Worth
The estimated net worth of Robert Silverman is at least $83,700 dollars as of 2025-04-26. Robert Silverman is the Senior VP, General Counsel of Concert Pharmaceuticals Inc and owns about 10,000 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $83,700. Details can be seen in Robert Silverman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Silverman has not made any transactions after 2015-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Silverman
Robert Silverman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Silverman owns 1 companies in total, including Concert Pharmaceuticals Inc (CNCE) .
Click here to see the complete history of Robert Silverman’s form 4 insider trades.
Insider Ownership Summary of Robert Silverman
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CNCE | Concert Pharmaceuticals Inc | 2015-09-18 | 10 percent owner & Senior VP & General Counsel |
Robert Silverman Latest Holdings Summary
Robert Silverman currently owns a total of 1 stock. Robert Silverman owns 10,000 shares of Concert Pharmaceuticals Inc (CNCE) as of September 18, 2015, with a value of $83,700.
Latest Holdings of Robert Silverman
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNCE | Concert Pharmaceuticals Inc | 2015-09-18 | 10,000 | 8.37 | 83,700 |
Holding Weightings of Robert Silverman
Robert Silverman Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Silverman has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 10,000 shares on September 18, 2015, which brought Robert Silverman around $200,000.
Insider Trading History of Robert Silverman
- 1
Robert Silverman Trading Performance
Robert Silverman Ownership Network
Ownership Network List of Robert Silverman
Ownership Network Relation of Robert Silverman
Robert Silverman Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Robert Silverman is the 10 percent owner & Senior VP & General Counsel of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Legal Officer Jeffrey A Munsie , Chief Development Officer James V Cassella , and CFO & PFO Marc A. Becker .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Robert Silverman Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Silverman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert Silverman's mailing address is: Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
